• FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS
  • Canada Rules EHP-101, Potential Cannabidiol Treatment, Not Controlled Substance
  • Bile Acid Supplements May Ease Symptoms of Progressive MS
  • MS News that Caught My Eye Last Week: COVID-19 and MS, Zeposia Approved, Talk Therapy, Temelimab Trial Postponed
  • CHMP Favors Zeposia (Ozanimod) as Oral Treatment for Active RRMS in EU
  • Way of Getting Nerve Cells to Restore Myelin-like Abilities Seen as Possible
  • Do They Know It’s Not Christmas?
  • Online Coronavirus Screening May Not Be Ready for Prime Time
  • Mix of Broad and Specific Language May Help in Talking About MS
  • Potential Competitor to Acthar Gel Asking to Re-enter US Market
  • Need to Know: MS and the Battlefield of the Immune System
  • A Life Unscripted: Choosing Positivity During a Pandemic
  • Helius Medical Technologies Authorized by Heath Canada to Market PoNS Device